Results 101 to 110 of about 6,623 (181)

OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule. [PDF]

BMJ Open, 2020
Perez Chacon G, Estcourt MJ, Totterdell J, Campbell DE, Perrett KP, Marsh JA, Richmond PC, Wood N, Gold MS, Holt PG, Waddington CS, Snelling TL.   +11 more
europepmc   +1 more source

A Phase 2b Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 6-Valent Group B Streptococcus Vaccine Administered Concomitantly With Tetanus, Diphtheria, and Acellular Pertussis Vaccine in Healthy Nonpregnant Female Individuals. [PDF]

J Infect Dis
Smith WB, Seger W, Chawana R, Skogeby Z, Silmon de Monerri NC, Feng Y, Gaylord M, Jongihlati B, Beeslaar J, Skinner JM, Bickham K, Anderson AS.   +11 more
europepmc   +1 more source

Immunogenicity and safety of co-administration with the Sabin-strain-based inactivated poliovirus vaccine (vero cell) and the diphtheria-tetanus-acellular pertussis vaccine in eligible children in China: a randomized, controlled, multicenter, non-inferiority trial. [PDF]

Front Immunol
Liu X, Han S, Chen X, Sun L, Wang R, Shi X, Guo Y, Wang H, Chen H, Chang S, Xu X, Zhang C, Wang Y, Zhang D, Hu W, Zhang S.   +15 more
europepmc   +1 more source

Acellular pertussis vaccines. [PDF]

Archives of Disease in Childhood, 1995
openaire   +2 more sources

Repeated Bordetella pertussis Infections Are Required to Reprogram Acellular Pertussis Vaccine-Primed Host Responses in the Baboon Model. [PDF]

J Infect Dis
Kapil P, Wang Y, Zimmerman L, Gaykema M, Merkel TJ.   +4 more
europepmc   +1 more source

Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. [PDF]

PLoS Med
Pérez Chacón G, Estcourt MJ, Totterdell J, Marsh JA, Perrett KP, Campbell DE, Wood N, Gold M, Waddington CS, O' Sullivan M, McAlister S, Curtis N, Jones M, McIntyre PB, Holt PG, Richmond PC, Snelling T.   +16 more
europepmc   +1 more source

Acellular Pertussis Vaccine Effectiveness Over Time. [PDF]

Pediatrics, 2019
Zerbo O, Bartlett J, Goddard K, Fireman B, Lewis E, Klein NP.   +5 more
europepmc   +1 more source

Estimating the Effectiveness of Acellular Pertussis Vaccines [PDF]

Clinical Infectious Diseases, 2012
Lara K, Misegades, Stacey W, Martin, Nancy E, Messonnier, Thomas A, Clark   +3 more
openaire   +2 more sources

Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age. [PDF]

Clin Infect Dis, 2020
Romanin V, Acosta AM, Juarez MDV, Briere E, Sanchez SM, Cordoba BL, Sevilla ME, Lucion MF, Urrutia A, Sagradini S, Skoff TH, Vizzotti C.   +11 more
europepmc   +1 more source

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis. [PDF]

NPJ Vaccines, 2019
Boehm DT, Wolf MA, Hall JM, Wong TY, Sen-Kilic E, Basinger HD, Dziadowicz SA, Gutierrez MP, Blackwood CB, Bradford SD, Begley KA, Witt WT, Varney ME, Barbier M, Damron FH.   +14 more
europepmc   +1 more source